StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a research note released on Thursday. The firm issued a buy rating on the stock.
Mannatech Trading Down 2.3 %
MTEX stock opened at $6.79 on Thursday. Mannatech has a 52-week low of $6.75 and a 52-week high of $15.10. The company has a quick ratio of 0.56, a current ratio of 1.08 and a debt-to-equity ratio of 0.09. The firm has a market cap of $12.77 million, a P/E ratio of -7.63 and a beta of 1.17. The company’s 50-day simple moving average is $7.71 and its 200-day simple moving average is $8.33.
Mannatech (NASDAQ:MTEX – Get Free Report) last issued its quarterly earnings results on Tuesday, May 14th. The company reported $0.63 earnings per share (EPS) for the quarter. The company had revenue of $29.39 million for the quarter. Mannatech had a negative return on equity of 15.37% and a negative net margin of 1.31%.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Featured Stories
- Five stocks we like better than Mannatech
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- How to Use Stock Screeners to Find Stocks
- MarketBeat Week in Review – 6/24 – 6/28
- Best Stocks Under $10.00
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
